Showing 7 posts of 142 posts found.

NICE thumbs up for Allergan’s Ozurdex

June 9, 2011
Sales and Marketing Allergan, BRVO, CVRO, NICE, Ozurdex

In draft guidance NICE has recommended the use of Allergan’s eye treatment Ozurdex.NICE’s final decision on Ozurdex (dexamethasone) is expected …

Allergan marketing breaches discredited industry

March 22, 2011
Medical Communications Allergan, Cephalon, PMCPA

Allergan, the manufacturer of Botox, has been censured for several breaches of the ABPI Code of Practice. The PMCPA watchdog …

European green light for Allergan’s Ozurdex

May 25, 2010
Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema

European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …

Allergan closes doors on Irish plant

May 8, 2009
Manufacturing and Production Allergan

US drugmaker Allergan has brought the curtain down on its manufacturing facility in Arklow, Ireland, months ahead of schedule. The …

GSK linked to Allergan takeover

March 26, 2009
Sales and Marketing Allergan, GSK

GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …

Restylane TV campaign a first for ‘cosmaceuticals’

June 18, 2008
Sales and Marketing Allergan, Eurocom, Restylane, disease awareness campaigns

The first European television adverts to promote a ‘cosmaceutical’ product have been broadcast in the UK.They feature Restylane, which is …

Allergan chooses UK for research base

June 16, 2006

US specialist pharmaceutical company Allergan has opened its new European research and development operations in Marlow in Buckinghamshire.Allergan is the …

Latest content